XML 58 R42.htm IDEA: XBRL DOCUMENT v3.20.1
STOCK BASED COMPENSATION (Narrative) (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
May 16, 2019
May 15, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Pricing model used in calculation of grant-date fair value Black-Scholes      
Expected dividend yield    
Expected volatility, minimum 60.00% 60.00%    
Expected volatility, maximum 80.50% 90.00%    
Risk-free interest rate, minimum 1.47% 1.89%    
Risk-free interest rate, maximum 2.71% 3.06%    
Unrecognized compensation expense related to non-vested market-based share awards $ 436,637      
Non Qualified Stock Options And Warrants [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Aggregate intrinsic value of options and warrants outstanding and exercisable $ 144,675      
Closing stock price of common stock $ 0.70      
Minimum [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expected option life 5 years 5 years    
Maximum [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expected option life 10 years 10 years    
Transaction One [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Warrants exercised   100,000    
Proceeds from warrants exercised   $ 61,500    
Transaction Two [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Warrants exercised   100,000    
Proceeds from warrants exercised   $ 100,000    
2007 Plan [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of common shares available to be purchased through options, issued and outstanding 4,450,000      
Number of shares authorized under plan 10,000,000      
2016 Plan [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of common shares available to be purchased through options, issued and outstanding 3,218,750      
Number of shares authorized under plan 3,000,000   8,000,000 3,000,000
Common stock remain available for grants 4,781,250      
Exercisable period 10 years